At Jan Medical Group, Dr
And other health and fitness articles on the Calo blog.
~100 Licensed Providers

Key TakeawaysGLP-1 drugs might lower the risk of dangerous blood clots and death among people with autoimmune diseasesPeople taking GLP-1 drugs were 44% less likely to dieThey also had a lower risk of blood clots in their lungs or causing a stroke.WEDNESDAY, June 17, 2026 (HealthDay News) People with an autoimmune disease and obesity might lower their risk of dangerous blood clots and death by taking Ozempic or Zepbound, a new study says.Autoimmune diseases like celiac disease, vitiligo, psoriasis or rheumatoid arthritis increase the risk of severe heath emergencies because they cause inflammation and malfunctioning immune responses, researchers said.But GLP-1 medications might be able to counter that risk, researchers reported recently in the Journal of the American Heart Association.Overall, peoples risk of death was cut by nearly half if they were taking a GLP-1 drug, the study found.In this real-world analysis, we found a consistent signal toward fewer serious complications including blood clots and lower mortality among patients treated with GLP-1 receptor agonists, senior researcher Dr

Still, one tester noted, It didnt have a ton of protein sources, so its not something Id look for in a premade meal since pasta is pretty easy to make myself. Premium meals like the filet mignon or surf-and-turf options felt smaller than expected and werent worth the extra cost for me
The antihypertensive activity of OS is due to its vasodilator and diuretic activities, the latter probably due to its binding with the renal adenosine A1 receptor (135)